Biomerics 宣布上海举一化工作为亚洲合作伙伴

Biomerics and Shanghai JuYi Chemical Co., Ltd Announce Asian Distributor Agreement

Salt Lake City, Utah, June 4, 2014 (BUSINESS WIRE) - Biomerics, a leading provider of medical polymers, is pleased to announce that Shanghai JuYi Chemical Co., Ltd has been named a distributor of its specialty medical grade thermoplastic polyurethanes in Asia. 

Shanghai JuYi Chemical Co., Ltd will distribute Biomerics full line of medical grade thermoplastic urethanes including Quadrathane™, Quadraflex™, and Quadraplast™.  Biomerics medical thermoplastic urethanes are used in a variety of medical device applications including vascular access catheters, introducers, drainage catheters, interventional radiology devices, fluid management products, coatings, balloons, and wound care. 

“Biomerics has partnered with Shanghai JuYi Chemical Co., Ltd based on their years of experience in the Asian medical device market and their extensive knowledge of medical urethanes, dependable distribution, and customer service,” said Travis Sessions, CEO of Biomerics. “Biomerics partnered with JuYi to increase access of our materials and technology to the Asian healthcare market.  Given their knowledge of the Asian medical market, it was a natural fit to select JuYi as our distribution partner”.

The Quadra Family of biomaterials are available in a wide range of hardness, colors, and radiopacifiers.  They are specifically engineered to meet the demanding quality and biocompatibility requirements of the medical device market and are ISO-10993 and USP Class VI compliant.  Biomerics and Shanghai JuYi Chemical will provide a standard stocking program for the most common material grades and will offer full service compounding and process support for custom applications.    

“The addition of Biomerics medical urethanes expands JuYi’s portfolio of elastomers for medical device manufacturers,” said Albert Zhou, President Shanghai JuYi Chemical Co., Ltd “Biomerics specialty offerings hold a distinctive position in the healthcare industry and are an excellent complement to our healthcare solutions strategy.”